Delirium and the functional recovery of older medical inpatients after acute illness: The significance of biological factors

Archives of Gerontology and Geriatrics

Volumn 52, Issue 3, 2011, Pages 276-280

  Adamis, Dimitrios ^a,b,d   Treloar, Adrian ^c   Gregson, Norman ^d   Macdonald, Alastair J D ^d   Martin, Finbarr C ^b  

^a UNIVERSITY OF WEST ATTICA   (Greece)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c OXLEAS NHS FOUNDATION TRUST   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

APOE genotype; Cytokines; Delirium in elderly; Functional ability of the elderly

Indexed keywords

APOLIPOPROTEIN E4; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; AGE DISTRIBUTION; AGED; APACHE; ARTICLE; BARTHEL INDEX; CONFUSION ASSESSMENT METHOD; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE RELEASE; DELIRIUM; DELIRIUM RATING SCALE; ELDERLY CARE; FEMALE; GENOTYPE; HOSPITAL PATIENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEX DIFFERENCE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; CYTOKINES; DELIRIUM; FEMALE; GERIATRIC ASSESSMENT; HUMANS; INPATIENTS; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION;

EID: 79953097115     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2010.04.006     Document Type: Article

References (42)

1. Adamis D. Procedure for Laboratory Assessments for Delirium Project 2007, http://www.psychopathology.org.uk/procedures/delirium/.
2. Adamis D. Statistical methods for analysing longitudinal data in delirium studies. Int. Rev. Psychiatry 2009, 21:74-85.
3. Adamis D., Treloar A., Martin F.C., Macdonald A.J.D. Recovery and outcome of delirium in elderly medical inpatients. Arch. Gerontol. Geriatr. 2006, 43:289-298.
4. Adamis D., Treloar A., Martin F.C., Gregson N., Hamilton G., Macdonald A.J. APOE and cytokines as biological markers for recovery of prevalent delirium in elderly medical inpatients. Int. J. Geriatr. Psychiatry 2007, 22:688-694.
5. Adunsky A., Levy R., Heim M., Mizrahi E., Arad M. The unfavorable nature of preoperative delirium in elderly hip fractured patients. Arch. Gerontol. Geriatr. 2003, 36:67-74.
6. Basu A., Krady J.K., Levison S.W. Interleukin-1: a master regulator of neuroinflammation. J. Neurosci. Res. 2004, 78:151-156.
7. Blazer D.G., Fillenbaum G., Burchett B. The APOE-E4 allele and the risk of functional decline in a community sample of African American and white older adults. J. Gerontol. A: Med. Sci. Biol. Sci. 2001, 56:M785-M789.
8. Bogardus S.T., Desai M.M., Williams C.S., Leo-Summers L., Acampora D., Inouye S.K. The effects of a targeted multicomponent delirium intervention on postdischarge outcomes for hospitalized older adults. Am. J. Med. 2003, 114:383-390.
9. Bruunsgaard H., Andersen-Ranberg K., Hjelmborg J.B., Pedersen B.K., Jeune B. Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am. J. Med. 2003, 115:278-283.
10. Cappola A.R., Xue Q.L., Ferrucci L., Guralnik J.M., Volpato S., Fried L.P. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J. Clin. Endocrinol. Metab. 2003, 88:2019-2025.
11. Cohen H.J., Pieper C.F., Harris T., Rao K.M., Currie M.S. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J. Gerontol. A: Biol. Sci. Med. Sci. 1997, 52:M201-M208.
12. Cohen H.J., Harris T., Pieper C.F. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am. J. Med. 2003, 114:180-187.
13. Dinarello C.A. Interleukin-1 family. The Cytokine Handbook 2003, 643-668. Academic Press, Amsterdam/London. A.W. Thomson, M.T. Lotze (Eds.).
14. Dolan M.M., Hawkes W.G., Zimmerman S.I., Morrison R.S., Gruber-Baldini A.L., Hebel J.R., Magaziner J. Delirium on hospital admission in aged hip fracture patients: prediction of mortality and 2-year functional outcomes. J. Gerontol. A: Biol. Sci. Med. Sci. 2000, 55:M527-M534.
15. El Solh A., Pineda L., Bouquin P., Mankowski C. Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markers. BMC Geriatr. 2006, 6:12.
16. Ely E.W., Girard T.D., Shintani A.K., Jackson J.C., Gordon S.M., Thomason J.W., Pun B.T., Canonico A.E., Light R.W., Pandharipande P., Laskowitz D.T. Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients. Crit. Care Med. 2007, 35:112-117.
17. Esperanza A., Miralles R., Rius I., Fernandez B., Digon A., Arranz P., Gonzalez P., Raja Y., Serrano P., Zafra M., Vazquez O., Gili P., Cervera A.M. Evaluation of functional improvement in older patients with cognitive impairment, depression and/or delirium admitted to a geriatric convalescence hospitalization unit. Arch. Gerontol. Geriatr. Suppl. 2004, 9:149-153.
18. Folstein M.F., Folstein S.E., McHugh P.R. " Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
19. Francis J., Kapoor W.N. Prognosis after hospital discharge of older medical patients with delirium. J. Am. Geriatr. Soc. 1992, 40:601-606.
20. Inouye S.K., van Dyck C.H., Alessi C.A., Balkin S., Siegal A.P., Horwitz R.I. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann. Intern. Med. 1990, 113:941-948.
21. Inouye S.K., Rushing J.T., Foreman M.D., Palmer R.M., Pompei P. Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. J. Gen. Intern. Med. 1998, 13:234-242.
22. Inouye S.K., Bogardus S.T., Charpentier P.A., Leo-Summers L., Acamphora D., Holford T.R., Cooney L.M. A multicomponent intervention to prevent delirium in hospitalized older patients. N. Engl. J. Med. 1999, 340:669-676.
23. Katz I.R., Curyto K.J., TenHave T., Mossey J., Sands L., Kallan M.J. Validating the diagnosis of delirium and evaluating its association with deterioration over a one-year period. Am. J. Geriatr. Psychiatry 2001, 9:148-159.
24. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit. Care Med. 1985, 13:818-829.
25. Krabbe K.S., Pedersen M., Bruunsgaard H. Inflammatory mediators in the elderly. Exp. Gerontol. 2004, 39:687-699.
26. Lundberg I.E., Dastmalchi M. Possible pathogenic mechanisms in inflammatory myopathies. Rheum. Dis. Clin. N. Am. 2002, 28:799-822.
27. Lynch J.R., Tang W., Wang H., Vitek M.P., Bennett E.R., Sullivan P.M., Warner D.S., Laskowitz D.T. APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J. Biol. Chem. 2003, 278:48529-48533.
28. Magaziner J., Zimmerman S.I., Gruber-Baldini A.L., Hebel J.R., Fox K.M. Proxy reporting in five areas of functional status. Comparison with self-reports and observations of performance. Am. J. Epidemiol. 1997, 146:418-428.
29. Mahoney F.I., Barthel D.W. Functional evaluation: the Barthel Index. Md. State. Med. J. 1965, 14:61-65.
30. Marcantonio E.R., Flacker J.M., Michaels M., Resnick N.M. Delirium is independently associated with poor functional recovery after hip fracture. J. Am. Geriatr. Soc. 2000, 48:618-624.
31. Marcantonio E.R., Kiely D.K., Simon S.E., John Orav E., Jones R.N., Murphy K.M., Bergmann M.A. Outcomes of older people admitted to postacute facilities with delirium. J. Am. Geriatr. Soc. 2005, 53:963-969.
32. McAvay G.J., Van Ness P.H., Bogardus S.T., Zhang Y., Leslie D.L., Leo-Summers L.S., Inouye S.K. Older adults discharged from the hospital with delirium: 1-year outcomes. J. Am. Geriatr. Soc. 2006, 54:1245-1250.
33. McCarron M.O., Muir K.W., Nicoll J.A., Stewart J., Currie Y., Brown K., Bone I. Prospective study of apolipoprotein E genotype and functional outcome following ischemic stroke. Arch. Neurol. 2000, 57:1480-1484.
34. McCusker J., Cole M., Dendukuri N., Han L., Belzile E. The course of delirium in older medical inpatients: a prospective study. J. Gen. Intern. Med. 2003, 18:696-704.
35. Miller R.R., Cappola A.R., Shardell M.D., Hawkes W.G., Yu-Yahiro J.A., Hebel J.R., Magaziner J. Persistent changes in interleukin-6 and lower extremity function following hip fracture. J. Gerontol. A: Biol. Sci. Med. Sci. 2006, 61:M1053-M1058.
36. Murray A.M., Levkoff S.E., Wetle T.T., Beckett L., Cleary P.D., Schor J.D., Lipsitz L.A., Rowe J.W., Evans D.A. Acute delirium and functional decline in the hospitalized elderly patient. J. Gerontol. 1993, 48:M181-M186.
37. Pompei P., Foreman M., Rudberg M.A., Inouye S.K., Braund V., Cassel C.K. Delirium in hospitalized older persons: outcomes and predictors. J. Am. Geriatr. Soc. 1994, 42:809-815.
38. Siddiqi N., House A.O., Holmes J.D. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing 2006, 35:350-364.
39. Teasdale G.M., Nicoll J.A., Murray G., Fiddes M. Association of apolipo-protein E polymorphism with outcome after head injury. Lancet 1997, 350:1069-1071.
40. Treger I., Froom P., Ring H., Friedman G. Association between apolipoprotein E4 and rehabilitation outcome in hospitalized ischemic stroke patients. Arch. Phys. Med. Rehabil. 2003, 84:973-976.
41. Trzepacz P.T., Baker R.W., Greenhouse J. A symptom rating scale for delirium. Psychiatry Res. 1988, 23:89-97.
42. Winkelman C. Inactivity and inflammation: selected cytokines as biologic mediators in muscle dysfunction during critical illness. AACN Clin. Issues 2004, 15:74-82.